This information is provided for educational context and does not constitute dosing guidance
The key thing to understand is that these are prescription medications with actual GLP-1 compounds in them
Clinical Evidence A study published in the New England Journal of Medicine followed 47 MCAS patients : 89% showed improvement in symptoms, including allergic, neurologic, digestive, and inflammation-related reactions Improvements happened within hours to days Only 13% experienced weight loss , and none became underweight Consistency is crucial
Whether you get semaglutide from MedVi (compounded) or Ro (brand-name Wegovy), the most common side effects are the same: nausea, constipation, diarrhea, stomach pain, and decreased appetite
The Problem with Older GLP-1 Pills: Earlier oral GLP-1s (like Rybelsus, which is oral semaglutide) are peptideschains of amino acids